BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 16286094)

  • 1. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene doping: of mice and men.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2009 Apr; 42(6):435-41. PubMed ID: 19272337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene doping.
    Azzazy HM
    Handb Exp Pharmacol; 2010; (195):485-512. PubMed ID: 20020377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A race to the starting line.
    Vogel G
    Science; 2004 Jul; 305(5684):632-5. PubMed ID: 15286358
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of candidate genes and expression profiles, as doping biomarkers].
    Paparini A; Impagnatiello F; Pistilli A; Rinaldi M; Gianfranceschi G; Signori E; Stabile AM; Fazio V; Rende M; Romano Spica V
    Ann Ig; 2007; 19(4):303-14. PubMed ID: 17937323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity-based biosensors as promising tools for gene doping detection.
    Minunni M; Scarano S; Mascini M
    Trends Biotechnol; 2008 May; 26(5):236-43. PubMed ID: 18367276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I abuse in sport: current knowledge and future prospects for detection.
    Guha N; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of doping with recombinant human growth hormone.
    He C; Wu M
    Bioanalysis; 2009 Aug; 1(5):953-65. PubMed ID: 21083065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
    Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
    Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and analogs.
    Reichel C; Gmeiner G
    Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human genome and sport, including epigenetics, gene doping, and athleticogenomics.
    Sharp NC
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):201-15, xi. PubMed ID: 20122459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch
    Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
    Nelson AE; Ho KK
    Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.